Abstract
Dent disease is an X-linked recessive disorder affecting the proximal tubule and is characterized by low-molecular-weight proteinuria (LMWP), hypercalciuria, nephrocalcinosis/nephrolithiasis with a variable number of features of Fanconi syndrome. It is most often associated with mutations in CLCN5, which encodes the endosomal electrogenic chloride/proton exchanger ClC-5. Renal acidification abnormalities are only rarely seen in Dent disease, whereas the hypokalemic metabolic alkalosis associated with hyperreninemic hyperaldosteronism (Bartter-like syndrome) has been reported in only one patient so far. We report on a 5-year-old boy with Dent disease caused by mutation in CLCN5 gene, c.1073G>A, who presented with hypokalemic metabolic alkalosis and hyperreninemic hyperaldosteronism persisting over the entire follow-up. No mutations were found in NKCC2, ROMK, NCCT, or ClC-Kb genes. In addition, the patient exhibited growth failure associated with partial growth hormone (GH) deficiency. Coexistence of Bartter-like syndrome features with LMWP should prompt a clinician to search for Dent disease. The Bartter syndrome phenotype seen in Dent disease patients may represent a distinct form of Bartter syndrome, the exact mechanism of which has yet to be fully elucidated. Growth delay that persists in spite of appropriate therapy should raise suspicion of other causes, such as GH deficiency.
This is a preview of subscription content, log in via an institution to check access.
References
Scheinman SJ (1998) X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations. Kidney Int 53:3–17
Ludwig M, Utsch B, Monnens LAH (2006) Recent advances in understanding the clinical and genetic heterogeneity of Dent’s disease. Nephrol Dial Transplant 21:2708–2717
Tosseto E, Ghiggeri GM, Emma F, Barbano G, Carrea A, Vezzoli G, Torregrossa R, Cara M, Ripanti G, Ammenti A, Peruzzi L, Murer L, Ratsch IM, Citron L, Gambaro G, D’Angelo A, Anglani F (2006) Phenotypic and genetic heterogeneity in Dent’s disease-the results of an Italian collaborative study. Nephrol Dial Transplant 21:2452–2463
Tosetto E, Ceol M, Mezzabotta R, Ammenti A, Peruzzi L, Caruso MR, Barbano G, Vezzoli G, Colussi G, Vergine G, Glorioso N, Degortes S, Soldati L, Sayer J, D’Angelo A, Anglani F (2009) Novel mutations of the CLCN5 gene including a complex allele and A 5’ UTR mutations in Dent disease 1. Clin Genet 76:413–416
Utsch B, Bökenkamp A, Benz MR, Besbas N, Dötsch J, Franke I, Fründ S, Gok F, Hoppe B, Karle S, Kuwertz-Bröking E, Laube G, Neb M, Nuutinen M, Ozaltin F, Rascher W, Ring T, Tasic V, van Wijk JAE, Ludwig M (2006) Novel OCRL1 mutations in patients with the phenotype of Dent disease. Am J Kidney Dis 48:942–954
Bökenkamp A, Böckenhauer D, Cheong HI, Hoppe B, Tasic V, Unwin R, Ludwig M (2009) Dent-2 disease: a mild variant of Lowe syndrome. J Pediatr 155:94–99
Besbas N, Ozaltin F, Jeck N, Seyberth H, Ludwig M (2005) CLCN5 mutation (R347X) associated with hypokalaemic metabolic alkalosis in a Turkish child: an unusual presentation of Dent’s disease. Nephrol Dial Transplant 20:1476–1479
Devuyst O, Konrad M, Jeunemaitre X, Zennaro M-C (2009) Tubular disorders of electrolyte regulation. In: Avner ED, Harmon WE, Niaudet P, Yoshikawa N (eds) Pediatric nephrology, 6th edn. Springer, Berlin Heidelberg New York, pp 929–976
Sheffer-Babila S, Chandra M, Speiser PW (2008) Growth hormone improves growth rate and preserves renal function in Dent disease. J Pediatr Endocrinol Metab 21:279–286
Smith AJ, Reed AA, Loh NY, Thakker RV, Lippiat JD (2009) Characterization of Dent’s disease mutations of CLC-5 reveals a correlation between functional and cell biological consequences and protein structure. Am J Physiol Renal Physiol 296:F390–F397
Rodriguez-Soriano J (2005) Tubular disorders of electrolyte regulation. In: Avner ED, Harmon WE, Niaudet P (eds) Pediatric nephrology, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 729–756
Fricker H, Frey K, Vallotton MB, Gugler E (1975) Bartter’s syndrome and tubular functional disturbances. Helv Paediatr Acta 30:61–77
Pennesi M, Marchetti F, Crovella S, Boaretto F, Travan L, Lazzerini M, Neri E, Ventura A (2005) A new mutation in two siblings with cystinosis presenting with Bartter syndrome. Pediatr Nephrol 20:217–219
Goto Y, Itami N, Kajii N, Tochimaru H, Endo M, Horai S (1990) Renal tubular involvement mimicking Bartter syndrome in a patient with Kearns-Sayre syndrome. J Pediatr 116:904–910
Günther W, Lüchow A, Cluzeaud F, Vandewalle A, Jentsch T (1998) ClC-5, the chloride channel mutated in Dent’s disease, colocalizes with the proton pump in endocytically active kidney cells. Proc Natl Acad Sci USA 95:8075–8080
Christensen EI, Devuyst O, Dom G, Nielsen R, Van Der Smissen P, Verroust P, Leruth M, Guggino WB, Courtoy PJ (2003) Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc Natl Acad Sci USA 100:8472–8477
Stechman MJ, Loh NY, Thakker RV (2009) Genetic causes of hypercalciuric nephrolithiasis. Pediatr Nephrol 24:2321–2332
Acknowledgements
The work was supported by the Ministry of Science, Republic of Serbia, grant no. 145046D. Mrs. B. Krsmanović provided an excellent assistance in preparing, and Mr. A. Iyengar in editing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bogdanović, R., Draaken, M., Toromanović, A. et al. A novel CLCN5 mutation in a boy with Bartter-like syndrome and partial growth hormone deficiency. Pediatr Nephrol 25, 2363–2368 (2010). https://doi.org/10.1007/s00467-010-1615-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-010-1615-x